Gerald D. Cagle, Director at AERIE PHARMACEUTICALS INC (AERI), bought 2,000 shares at $41.60 ($83K) on 2017-04-19, disclosed to the SEC on 2017-04-20.
Open-market purchase of $83k AERI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.60 | 1,000 | $42K | 49.9% |
| 2 | $41.80 | 1,000 | $42K | 50.1% |
| Total | $41.70 avg | 2,000 | $83K | 100% |
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |